论文部分内容阅读
目的 探讨腮腺癌颈淋巴结的手术处理。方法 回顾作者所收治的 2 44例腮腺癌病人 ,分析其颈淋巴结转移、处理及转归。结果 发现全组颈淋巴结转移率为 32 .4% ,首发癌为 2 8.7% ,复发癌为 46 .5 %。不同病理类型颈淋巴结转移率为 0 %～ 73.3%不等。肿瘤T1～T4分期 ,颈淋巴结转移率为 10 %～ 6 8.8%。 16 0例N0病人颈淋巴结转移率为 16 .3% ,84例N+病人颈淋巴结转移率为 6 3.1%。结论 认为腮腺癌N+病人应作治疗性颈清术 ,N0病人是否作选择性颈清术 ,病理类型是主要依据 ,但还要结合临床分期及是否为复发病例。
Objective To investigate the surgical treatment of parotid gland neck lymph node. Methods The authors reviewed 244 cases of parotid adenocarcinoma patients, analysis of cervical lymph node metastasis, management and outcome. The results showed that the whole group of cervical lymph node metastasis rate was 32.4%, the first cancer was 2 8.7%, 46.5% of recurrent cancer. Different pathological types of cervical lymph node metastasis rate of 0% to 73.3%. T1 ~ T4 tumor stage, cervical lymph node metastasis rate of 10% to 6 8.8%. The cervical lymph node metastasis rate was 16.3% in 160 cases of N0 patients and 61.1% in 84 cases of N + patients. Conclusions: The patients with N + parotid adenocarcinoma should be treated with cervical nephrolithotomy, and whether N0 patients should be treated by selective necking. The pathological type is the main basis, but it should be combined with clinical stage and whether it is recurrence.